Max Zeller Söhne AG
Max Zeller Söhne AG specialises in the development, production and marketing of phyto-pharmaceuticals with clinically proven efﬁcacy, safety and tolerability.
Zeller is a leader in the Swiss market for phyto-pharmaceuticals and one of the few companies that controls the entire value chain from seed to ﬁnished product. At the Zeller sites in Romanshorn and Uttwil (VitaPlant), there are 135 employees in diverse disciplines such as biology, agriculture, process engineering, pharmacy and medicine. Patients beneﬁt from Zeller’s phyto-pharmaceuticals both in Switzerland and worldwide.
Medis doo is the leading commercialization partner for innovative companies in the CSEE region. With 29 years of experience, we have proven our capabilities and reliability to many most admired pharmaceutical/biotech companies. We have the highest financial rating, 300+ employees and strong presence in hospital and retail.
Medis is looking for new cutting-edge medical solutions, to address unmet medical needs in the CSEE.
MergerMotives GmbH - The M&A Consulting Boutique
"Customized support for Mergers & Acquisitions, In- and Outlicensing, Business Development and other related areas".
We are a small and specialized M&A consulting boutique with a young and innovative mindset that is advising and supporting its clients in Mergers & Acquisitions, In- and Outlicensing, Business Succession, Business Development and other related areas. Our clients are companies from various industries all around the world that either do not have their own Business Development team or that need some additional temporary resources for their M&A team.
Mundipharma is a global, independent network empowered locally.
We are an asset led, privately owned business, with international presence and in-depth knowledge of the local market.
Our network of independent affiliated companies enables us to leverage our integrated capabilities from discovery to product commercialization.
Built on a tradition of entrepreneurship, our flexibility and way of doing things have allowed us to forge a solid and trustful relationship with our partners, ensuring the sustained success of our business.
Focused on delivering commercial excellence, we actively evaluate opportunities to complement our existing product portfolio, to substantially improve patient’s quality of life.